These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12234455)

  • 1. Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice: a randomised controlled trial.
    Zermansky AG; Petty DR; Raynor DK; Lowe CJ; Freemantle N; Vail A
    Health Technol Assess; 2002; 6(20):1-86. PubMed ID: 12234455
    [No Abstract]   [Full Text] [Related]  

  • 2. Outside the box.
    Greenhalgh T
    Br J Gen Pract; 2013 Jul; 63(612):369. PubMed ID: 23834870
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice.
    Zermansky AG; Petty DR; Raynor DK; Freemantle N; Vail A; Lowe CJ
    BMJ; 2001 Dec; 323(7325):1340-3. PubMed ID: 11739221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication review for older people in general practice.
    Iliffe S
    J R Soc Med; 1994; 87 Suppl 23(Suppl 23):11-3. PubMed ID: 8064764
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical care for elderly patients shared between community pharmacists and general practitioners: a randomised evaluation. RESPECT (Randomised Evaluation of Shared Prescribing for Elderly people in the Community over Time) [ISRCTN16932128].
    Wong I; Campion P; Coulton S; Cross B; Edmondson H; Farrin A; Hill G; Hilton A; Philips Z; Richmond S; Russell I
    BMC Health Serv Res; 2004 Jun; 4(1):11. PubMed ID: 15182379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety.
    Cox N; Tak CR; Cochella SE; Leishman E; Gunning K
    J Am Board Fam Med; 2018; 31(1):105-112. PubMed ID: 29330245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial.
    Zermansky AG; Alldred DP; Petty DR; Raynor DK; Freemantle N; Eastaugh J; Bowie P
    Age Ageing; 2006 Nov; 35(6):586-91. PubMed ID: 16905764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of family physician prescribing: influence of the clinical pharmacist.
    Carter BL; Helling DK; Jones ME; Moessner H; Waterbury CA
    Drug Intell Clin Pharm; 1984 Oct; 18(10):817-21. PubMed ID: 6489164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial.
    Lenander C; Elfsson B; Danielsson B; Midlöv P; Hasselström J
    Scand J Prim Health Care; 2014 Dec; 32(4):180-6. PubMed ID: 25347723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication reviews in the community: results of a randomized, controlled effectiveness trial.
    Sorensen L; Stokes JA; Purdie DM; Woodward M; Elliott R; Roberts MS
    Br J Clin Pharmacol; 2004 Dec; 58(6):648-64. PubMed ID: 15563363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does a primary care practice pharmacist improve the timeliness and completion of medication management reviews?
    Freeman C; Cottrell WN; Kyle G; Williams I; Nissen L
    Int J Pharm Pract; 2012 Dec; 20(6):395-401. PubMed ID: 23134099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary care. Diverted traffic.
    Hassell K
    Health Serv J; 2000 Jan; 110(5686):22-3. PubMed ID: 11184386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions.
    Bond C; Matheson C; Williams S; Williams P; Donnan P
    Br J Gen Pract; 2000 Apr; 50(453):271-5. PubMed ID: 10897509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring factors associated with patients' satisfaction with medication change: a questionnaire survey.
    Rodgers S; Avery AJ; O'Neill C
    Br J Gen Pract; 2002 Aug; 52(481):655-7. PubMed ID: 12171225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Home medicines reviews - do they change prescribing and patient/pharmacist acceptance?
    Quirke J; Wheatland B; Gilles M; Howden A; Larson A
    Aust Fam Physician; 2006 Apr; 35(4):266-7. PubMed ID: 16642247
    [No Abstract]   [Full Text] [Related]  

  • 16. Who controls repeats?
    Zermansky AG
    Br J Gen Pract; 1996 Nov; 46(412):643-7. PubMed ID: 8978109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).
    Tan EC; Stewart K; Elliott RA; George J
    Res Social Adm Pharm; 2014; 10(4):623-32. PubMed ID: 24095088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication prescribing advice and drug utilization: a review from the United Kingdom.
    Law J; Thompson A
    Pharm Pract Manag Q; 1996 Jan; 15(4):27-35. PubMed ID: 10153842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs and professional interactions: the modern day pharmacist.
    Petty D
    Heart; 2003 May; 89 Suppl 2(Suppl 2):ii31-2; discussion ii35-7. PubMed ID: 12695434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trade names or approved names. Part II. Points of view. The retail pharmacist.
    Haberfield GR
    Postgrad Med J; 1974 Feb; 50(580):81-2. PubMed ID: 4465779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.